drug discovery

News

scientifically visualization of a coronavirus spike protein

Gates Foundation backs COVID R&D at AI firm Exscientia

Artificial intelligence-based drug discovery company Exscientia is stepping up its search for new COVID-19 medicines, thanks to an award by the Bill & Melinda Gates Foundation.

News

Science Molecule, Molecular DNA Model Structure, business teamwork conceptMolecular, DNA and atom model in science research labMolecular, DNA and atom model in science research lab setting in studio.

BMS embraces AI drug discovery with $1.2bn Exscientia allian...

Exscientia has signed up another big pharma partner for its artificial intelligence (AI) based drug discovery platform, this time attracting a $50 million upfront buy-in from Bristol-Myers

News

Closeup of X-ray photography of human brain

Exscientia starts trials of AI-designed Alzheimer's drug

Exscientia has advanced a drug candidate for Alzheimer's disease into human testing, the third clinical-stage project for the UK specialist in artificial intelligence (AI) based drug discov

News

AI implementation for pharma and healthcare

Exscientia starts trials of first AI-derived cancer immunoth...

Exscientia was the first company to start human trials of a new drug designed using artificial intelligence (AI) last year, and now says it has started testing of the first AI candidate for

News

AI drug discovery player 1910 Genetics debuts with $26m war ...

There's a new kid on the block among companies using artificial intelligence in drug discovery, after 1910 Genetics launched today with $26 million in financing.

News

Protein misfolding specialist Gain nets $40m from IPO

Gain Therapeutics has priced its initial public offering, raising more than $40 million for its computational drug discovery platform and pipeline of drugs for diseases associated with prot

Gates Foundation backs COVID R&D at AI firm Exscientia

BMS embraces AI drug discovery with $1.2bn Exscientia allian...

Exscientia starts trials of AI-designed Alzheimer's drug

Exscientia starts trials of first AI-derived cancer immunoth...

AI drug discovery player 1910 Genetics debuts with $26m war ...

Protein misfolding specialist Gain nets $40m from IPO

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

drug discovery

Editor's Picks